XOMA Corp (XOMA) Stock Analysis

XOMA Corp (XOMA) is a publicly traded company in the HEALTHCARE sector. It trades at $41.69, carries a market capitalization of $522.84M, a price-to-earnings ratio of 26.55. This page summarizes the public market data, fundamentals, and frequently asked questions for XOMA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $41.69
• Market Cap: $522.84M
• P/E Ratio: 26.55
• EPS: $1.57
• 52-Week High: $42.81
• 52-Week Low: $22.29

Market Sentiment

XOMA Corp currently has a Bullish sentiment score of 0.22.

About XOMA Corp

XOMA Corporation is a biotechnology firm headquartered in Emeryville, California, specializing in the discovery and development of innovative therapeutic candidates through its distinctive royalty aggregation model. By collaborating with biopharmaceutical companies, XOMA advances treatments across multiple disease areas, capitalizing on its expertise in antibody development and robust clinical and regulatory programs. With operations extending into the United States, Europe, and the Asia Paci...

GNG Research Analysis

GNG Research scores XOMA Corp (XOMA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for XOMA.

Frequently Asked Questions

Does XOMA pay dividends?

XOMA Corp (XOMA) does not currently pay a regular dividend.

What is XOMA's P/E ratio?

XOMA Corp has a price-to-earnings (P/E) ratio of 26.55.

What is XOMA's market cap?

XOMA Corp (XOMA) has a market capitalization of $522.84M with a current stock price of $41.69.